Skip to main content
SERA logo

Sera Prognostics, Inc.

SERANASDAQHealthcareMedical Devices

$2.04Today:- (-)1Y −39.10%

As of Oct 26, 2026 close

Market cap
$102.97M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.56$3.95
Volume (live)
-
Avg. volume (3M)
15.92K

Sera Prognostics (SERA) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Sera Prognostics used $25.62M of cash in operating activities and spent $726.00K on capital expenditures. That left free cash flow of −$26.35M.

Sera Prognostics Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Sera Prognostics, Inc. (SERA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-31.93-32.90-36.24-44.19-35.01-19.85-16.52
Depreciation & Amortization0.940.830.900.760.660.900.95
Stock Based Compensation5.117.015.275.063.130.730.44
Change in Working Capital-0.5511.283.523.55-0.04-0.31-3.65
Change in Accounts Receivable0.0211.42-5.36-2.97-3.140.000.01
Change in Accounts Payable-1.010.46-0.440.350.60-0.31-0.53
Change in Other Working Capital0.44-0.010.470.450.680.00-3.12
Other Operating Activities0.80-0.41-0.640.450.681.67-0.54
Net Cash from Operating Activities-25.62-14.19-27.19-34.61-31.64-16.87-19.32
Investing Activities
Capital Expenditures-0.73-0.06-0.13-0.79-1.30-0.15-0.11
Purchases of Investments-87.61-35.83-54.14-48.07-82.060.000.00
Sales/Maturities of Investments59.8448.6854.4054.400.800.000.00
Other Investing Activities0.00-1.050.310.020.000.000.10
Net Cash from Investing Activities-28.5011.740.445.55-82.56-0.15-0.01
Financing Activities
Debt Repayment-0.19-0.44-0.47-0.30-7.66-1.702.99
Common Stock Issued54.223.051.220.3166.610.000.90
Other Financing Activities0.00-0.44-0.47-0.301.0710.8629.16
Net Cash from Financing Activities54.032.610.750.01159.599.1633.05
Summary
Net Change in Cash-0.100.16-26.00-29.0545.40-7.8613.72
Cash at Beginning of Period4.043.8829.8858.9313.5321.397.67
Cash at End of Period3.944.043.8829.8858.9313.5321.39
Free Cash Flow-26.35-14.25-27.32-35.40-32.94-17.02-19.43
Supplemental Disclosures
Interest Paid-0.030.060.051.190.25-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sera Prognostics Cash Flow

What is Sera Prognostics's free cash flow?

Sera Prognostics had negative free cash flow of $26.35M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$25.62M minus $726.00K of capital expenditures.

How much does Sera Prognostics spend on capital expenditures?

Sera Prognostics spent $726.00K on capital expenditures in fiscal 2025, compared with $56.00K a year earlier.

Does Sera Prognostics pay dividends or buy back shares?

Sera Prognostics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition